Autoimmune Lymphoproliferative Syndrome with Somatic Fas Mutations

  • Holzelova E
  • Vonarbourg C
  • Stolzenberg M
  • et al.
301Citations
Citations of this article
141Readers
Mendeley users who have this article in their library.

Abstract

BACKGROUND: Impaired Fas-induced apoptosis of lymphocytes in vitro is a principal feature of the autoimmune lymphoproliferative syndrome (ALPS). We studied six children with ALPS whose lymphocytes had normal sensitivity to Fas-induced apoptosis in vitro. METHODS: Susceptibility to Fas-mediated apoptosis and the Fas gene were analyzed in purified subgroups of T cells and other mononuclear cells from six patients with ALPS type III. RESULTS: Heterozygous dominant Fas mutations were detected in the polyclonal double-negative T cells from all six patients. In two patients, these mutations were found in a fraction of CD4+ and CD8+ T cells, monocytes, and CD34+ hematopoietic precursors, but not in hair or mucosal epithelial cells. CONCLUSIONS: Somatic heterozygous mutations of Fas can cause a sporadic form of ALPS by allowing lymphoid precursors to resist the normal process of cell death.

Cite

CITATION STYLE

APA

Holzelova, E., Vonarbourg, C., Stolzenberg, M.-C., Arkwright, P. D., Selz, F., Prieur, A.-M., … Rieux-Laucat, F. (2004). Autoimmune Lymphoproliferative Syndrome with Somatic Fas Mutations. New England Journal of Medicine, 351(14), 1409–1418. https://doi.org/10.1056/nejmoa040036

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free